Rajkumar Verma
Assistant Professor · UConn Health · University of Connecticut
Quick answer: Rajkumar Verma is Assistant Professor at University of Connecticut. Rajkumar Verma shows an active PhD hiring signal as of 2026-09-11.
⭐ A postdoctoral research fellow position is available in the group of Rajkumar Verma in the Neuroscience Department, University of Connecticut School of Medicine, Farmington CT. Verma lab studies mechanisms of recovery in a rodent model of ischemic stroke injury. The current focus of Verma lab is to explore the role of purinergic receptors in neuro-inflammation after stroke (NIH R01 funded) and val
Research interests
My lab investigates the cause-effect-relationships of stroke outcome. we focus on following three specific areas of stroke research. Project 1: Stroke remains a leading cause of disability in the United States. Despite recent advances, interventions to reduce damage and enhance recovery after stroke are absent. In this project we will investigate a novel drug target “Purinergic receptor P2X4” for therapeutic exploitation in stroke. We will determine how the inhibition of P2X4R signaling influences these excessive immune during stroke using mice genetically engineered for global or selective deletion of P2X4R in total myeloid or infiltrating myeloid population and also by using pharmacological modulation. The overall goal of this project is to determine if modulation of P2X4R signaling in myeloid cells is a viable therapy for stroke, working towards our long-term goal of developing and identifying target-based therapies for stroke. Project 2: Encephalomyosynangiosis (EMS) is a neurosurgical procedure with low morbidity that is applied to promote collateral vascular formation in patients with moyamoya disease, a condition with progressive narrowing of cranial arteries and consequent low blood flow that increases risk for ischemic stroke. The procedure involves placement of a temporalis muscle flap on ischemic brain tissue. Human data suggest that extensive collateral formation occurs within a few months after EMS in patients with moyamoya disease. Therefore, it was hypothesized that EMS, which provides a local and robust tissue as a source of vascular endothelium and angiogenic growth factors, will supply growth factors for angiogenesis that could promote neuronal survival following ischemic stroke. As a proof of concept, We have established EMS surgery for the first time in mice after ischemic stroke. Preliminary data from this model show that EMS surgery temporalis muscle graft was bonded to the cortical surface after 21 days. Additionally, mice receiving EMS after stroke show increased lectin-positive blood vessel formation at 21 days and showed behavioral recovery compared to stroke mice that did not receive EMS. These data indicate that EMS may be a safe and feasible treatment to restore blood supply to ischemic tissue; however, more in-depth, longer-term studies are needed. Therefore, this model will be used to further investigate EMS for treating ischemic stroke fot the following overall goal to determine if EMS promotes angiogenesis after non-moyamoya ischemic stroke, and to determine if EMS promotes long-term functional recovery after non-moyamoya ischemic stroke. Project 3: MicroRNAs (miRNAs) are short non-coding RNAs and have emerged as a powerful intervention tool for many diseases including stroke. They regulate a broad spectrum of biological pathways through fine-tuning of protein expression levels and altering gene expression levels. miRNA can concurrently target multiple effectors of pathways involved in stroke pathology. In this project we focus on the differential expression of miRNA expressed in mice after stroke and determine if blocking (with genetic deletion or antagomirs) or enhancing (mimics) these target miRNA modulates their effects. The overall goal our lab is to determine if manipulation of target miRNAs can improve functional recovery after stroke.
Selected publications (since 2023)
Effect of encephalomyosynangiosis procedure on post stroke recovery in a permanent model of ischemic stroke. Diaz, Anthony; Gamiotea-Turro, Daylin; Yadav, Sanjeev Kumar; Bulsara, Ketan R; Verma, Rajkumar Experimental neurology 2026 Feb;396:115559
Validation and Optimization of Breeding Strategy for miR-141/200c Knockout Mice to Eliminate Off-Target Gene Silencing using FLPo Deleter. Srivastava, Rashmi; Yadav, Sanjeev Kumar; Cormier, Mary-Catherine; Lowther, Katie; Yee, Siu-Pok; Verma, Rajkumar bioRxiv : the preprint server for biology 2025 Oct;
TRPM2 overactivation drives hyperlipidemia-induced dysfunction of myeloid cells and neurovascular units. Zong, Pengyu; Li, Cindy; Feng, Jianlin; Yue, Zhichao; Legere, Nicholas; Yu, Albert S; Shah, Fahad; Perez, Adrianna; Li, Zhu; Jellison, Evan; Mor
Frequently asked questions
Is Rajkumar Verma hiring PhD students at University of Connecticut?
Yes. As of 2026-09-11, Rajkumar Verma's faculty page shows a PhD hiring signal: A postdoctoral research fellow position is available in the group of Rajkumar Verma in the Neuroscience Department, University of Connecticut School of Medicine, Farmington CT. Verma lab studies mecha.
What does Rajkumar Verma research?
My lab investigates the cause-effect-relationships of stroke outcome. we focus on following three specific areas of stroke research. Project 1: Stroke remains a leading cause of disability in the United States. Despite recent advances, interventions to reduce damage and enhance recovery after stroke
Data last updated: 2026-09-11 · Source: phd-match.com faculty database.
Is Rajkumar Verma a match for your research?
Upload your CV and get matched to professors who fit — with hiring signals.
Start matching